8-aminomethyl-3-boc-3-azabicyclo[3.2.1]octane hydrochloride, 95.0%, 250mg

2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate, 97.0%, 10g

(R)-tert-butyl 2-(2-(benzyloxycarbonylamino)-2-phenylacetamido)acetate, 98%, 1g

2-(3-METHOXYPHENOXY)ACETONITRILE, 97.0%, 250mg

1-(tert-Butoxycarbonyl)-5-oxopiperidine-2-carboxylic acid, 95.0%, 1g

(R)-Ethyl 6-(4-phenyl-4,5-dihydrooxazol-2-yl)nicotinate, 98%, 250mg

2-(3-Chloro-5-(cyclopropylmethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

tert-Butyl 4-(4-Bromophenyl)piperazine-1-carboxylate>98.0%(T)5g

2,4-Dichloro-N-pyrrolidin-2-ylmethyl-benzenesulfonamide hydrochloride, 95.0%, 250mg

1-(Tetrahydro-2H-pyran-2-yl)-1H-indazole-5-boronic acid, 95.0%, 250mg

H-Ser(tBu)-OMe.HCl, 95%, 5g

2-Mercapto-6-methyl-4-(trifluoromethyl)nicotinonitrile, 97.0%, 250mg

Triethylsulfonium-bis-(trifluoromethyl-, sulfonyl)-imide min. 99%, 100 g, glass packaging